RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations Laura Conejero Hall , Luis Puente Maestu , Myriam Calle Rubio , Walter Giron , Carlos Jose Alvarez Martinez , Maria Jesus Buendia Garcia , Joan Serra Batlles , Juan Luis Rodriguez Hermosa , Soledad Alonso Viteri , Julia Garcia De Pedro , Paola Benedetti , Javier De Miguel Diez , Jose Luis Alvarez-Sala Walther , Julio Hernandez Vazquez , Francisco Garcia Rio , Carmen Rodriguez Sainz , Cristina Fernandez Perez , Ana Doyle , Raquel Caballero , Jose Luis Subiza , Miguel Casanovas , Eduardo Fernandez-Cruz EUROPEAN RESPIRATORY JOURNAL（2021）
关键词
COPD - management, Immunology, Vaccination
AI 理解论文
溯源树
样例
